| Literature DB >> 15073525 |
Kathleen M Pettifer1, Sonya Kleywegt, Christian J Bau, James D Ramsbottom, Eva Vertes, Renata Ciccarelli, Francesco Caciagli, Eva S Werstiuk, Michel P Rathbone.
Abstract
Apoptosis is implicated in the pathophysiology of Alzheimer's disease. Extracellular guanosine inhibits staurosporine-induced apoptosis in astrocytes. We examined whether guanosine protects SH-SY5Y human neuroblastoma cells against beta-amyloid(betaA)-induced apoptosis. Addition of betaA (fragment 25-35, 5 microM for 24 h) to SH-SY5Y cells increased the number of apoptotic cells, as evaluated by oligonucleosome ELISA. Guanosine pre-treatment decreased betaA-induced apoptosis (maximal effect after 24 h, 300 microM, p<0.05). The anti-apoptotic effect of guanosine was reduced by LY294002 (PI3K inhibitor) or PD98059 (MEK inhibitor) (p<0.05). Guanosine increased phosphorylation of Akt/PKB, and this was abolished by inhibiting PI3K or MEK, (p<0.001, 5 min). Thus, the protective effect of guanosine against betaA-induced apoptosis of SH-SY5Y cells is mediated via activation of the PI3K/Akt/PKB and MAPK pathways.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15073525 DOI: 10.1097/00001756-200404090-00019
Source DB: PubMed Journal: Neuroreport ISSN: 0959-4965 Impact factor: 1.837